GSK plc Current Tax Relating To Items Charged Or Credited Directly To Equity
GSK plc (GLAXF) reported Current Tax Relating To Items Charged Or Credited Directly To Equity of GBP 7.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2026-03-06
| Period end | Current Tax Relating To Items Charged Or Credited Directly To Equity 12 month | Current Tax Relating To Items Charged Or Credited Directly To Equity 12 month as first filed |
|---|---|---|
| 2025-12-31 | 7.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 0.00 GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | -150.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 9.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 41.00M GBP 20-F · filed 2024-03-05 | |
| 2020-12-31 | 83.00M GBP 20-F · filed 2023-03-10 | 69.00M GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 17.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | -2.00M GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 26.00M GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 39.00M GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 52.00M GBP 20-F/A · filed 2018-03-20 |